Skip to main content
Smart Investors Daily
Electromed, Inc. logo

AMEX · ELMD

Electromed, Inc.

Healthcare · Medical - Devices

$28.32

Down-$0.05 (-0.18%)

Updated Oct 6, 2026, 9:41 PM

SID Score

4.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
247.23M
P/E ratio
32.78
Dividend yield
0.00%
52-week range
$23.01 – $47.40
Volume
69.54K
Avg. volume
49.48K

Price performance · ELMD

ELMD price history

1M range · 0 trading sessions · Daily adjusted prices

ELMD does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest ELMD news

The latest Smart Investors Daily articles mentioning ELMD.

ELMD research

Overview

Company profile and research snapshot.

Company profile

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$35.50
Implied upside
—
Analysts
—
ELMD recent ratings
DateFirmRatingTarget
Aug 26, 2026Lake StreetBuy—
May 13, 2026B. Riley SecuritiesBuy—
Nov 13, 2025Roth CapitalBuy—
Aug 27, 2025Roth CapitalBuy—
Jul 22, 2025Roth CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 3, 2026

Electromed (ELMD) Keeps Growing While Wall Street Barely Notices

On August 25, Electromed (NASDAQ:ELMD) reported fiscal fourth-quarter results that extended a streak few small-cap medical device companies can claim: fifteen consecutive quarters of year-over-year revenue and profit growth. Net revenue hit a record $19.4 million, up 11.6% from a year earlier, and diluted earnings per share climbed to $0.39 from $0.25. Those headline numbers […]

SeekingAlpha · Aug 28, 2026

Electromed: Contrarian 'Buy' With SmartVest

After Electromed’s selloff, explore SmartVest growth drivers, underpenetrated bronchiectasis market, reimbursement outlook, and why the stock looks like a...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.